Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Apr, 2015 | Pages:
1280 | Publisher: RESEARCH IMPACT TECHNOLOGIES
Industry: Biotechnology | Report Format: Electronic (PDF)
This market insight report on Unnatural Amino Acids gives an insight into the different types of Unnatural Amino Acids (ß-Amino Acids, ß-Amino Acid Derivatives, Cyclic Amino Acids & Derivatives, D-Amino Acids, D-Amino Acid Derivatives, DL-Amino Acids, DL-Amino Acid Derivatives, L-Amino Acid Derivatives and Other ) and their application areas such as R&D, Pharmaceutical, Food & Feed, Agrochemicals and Other. The study includes estimations and predictions for 2005 -2020 for the global Unnatural Amino Acids market by type and applications. Regional Analysis is covered separately for North America (United States and Canada); Europe (UK, Germany, Switzerland, Italy, The Netherlands, and Rest of Europe); Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific); and Rest of World. The text is complemented with graphical representations of 318 exhibits. Business profiles of 61 major companies are discussed in the report. The report serves as a guide to global Unnatural Amino Acids industry covering more than 1100 companies that are engaged in Unnatural Amino Acids R&D, synthesis, discovery, testing and supply of derivatives, products and services. Compilation of Worldwide Patents and Research related to Unnatural Amino Acids is also provided. Information related to industrial activity, corporate developments, research trends, product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.
Table of Content 1. SCOPE AND METHODOLOGY 1 2. REPORT SYNOPSIS 4 2.1 Unnatural Amino Acids – An Introduction 4 Amino Acids 4 Types of Amino Acids 5 Essential Amino Acids 5 Non-Essential Amino Acids 5 Proteinogenic Amino Acids 5 Unnatural Amino acids 5 Non-Proteinogenic Amino Acids 6 Non-Standard Amino Acids 6 Synthetic Unnatural Amino Acids 6 2.2 Segmentation of Unnatural Amino Acids 7 Exhibit 1. Segmentation of Unnatural Amino Acids Market by Type and Application 7 Unnatural Amino Acids - Definitions, Important Facts & Figures 7 β-Amino Acids & Derivatives 7 β-Amino acids 7 β-Alanine 7 Synonyms 8 Molecular Formula 8 Molecular Weight 8 Structure 8 Synthesis 8 IUPAC Name 8 β-methylphenylalanine 8 β-Amino Alcohols 8 Synthesis 8 Cyclic Amino Acids & Derivatives 9 Cyclic β-Amino Acids 9 Cyclic Unnatural α-Amino Acids 9 D-Cycloserine 9 Synonyms 9 Molecular Formula 9 Molecular Weight 9 Structure 9 IUPAC Name 9 D-Amino Acids & Derivatives 9 D-Cysteine 10 Synonyms 10 Molecular Formula 10 Molecular Weight 10 Structure 10 Synthesis 11 IUPAC Name 11 D-Serine 11 Synonyms 11 Molecular Formula 11 Molecular Weight 11 Structure 11 IUPAC Name 12 D-Proline 12 Synonyms 12 Molecular Formula 12 Molecular Weight 12 Structure 13 IUPAC Name 13 D-Valine 13 Synonyms 13 Molecular Formula 14 Molecular Weight 14 Structure 14 Synthesis 14 IUPAC Name 14 D-Alanine 14 Synonyms 14 Molecular Formula 15 Molecular Weight 15 Structure 15 Synthesis 15 IUPAC Name 15 D-Phenylalanine 15 Synonyms 16 Molecular Formula 16 Molecular Weight 16 Synthesis 16 IUPAC Name 16 D-Citrulline /D-Citrulene 16 Synonyms 16 Molecular Formula 16 Molecular Weight 16 Structure 16 IUPAC Name 17 D-Tryptophan 17 Synonyms 17 Molecular Formula 17 Molecular Weight 17 Structure 17 Synthesis 17 IUPAC Name 17 D-Lysine 18 Synonyms 18 Molecular Formula 18 D-Leucine 18 Synonyms 18 Molecular Formula 18 Molecular Weight 18 Structure 18 D-Histidine 19 Histidine 19 Synonyms 19 Molecular Formula 19 Molecular Weight 19 IUPAC Name 19 D-Glutamic Acid 19 Synonyms 20 Molecular Formula 20 Molecular Weight 20 Structure 20 D-Methionine 20 Synonyms 21 Molecular Formula 21 Molecular Weight 21 D-Aspartic Acid 21 Neurotransmitter 21 Synonyms 21 Molecular Formula 22 Molecular Weight 22 Structure 22 IUPAC Name 22 D-Tyrosine 22 Synonyms 22 Molecular Formula 23 Molecular Weight 23 Structure 23 IUPAC Name 23 D-Arginine 23 D-Threonine 23 Synonyms 24 Molecular Formula 24 Molecular Weight 24 Structure 24 IUPAC Name 24 D-Phenylglycine 24 Synonyms 24 Molecular Formula 25 Molecular Weight 25 Structure 25 IUPAC Name 25 D-p-hydroxy phenylglycine 25 Synonyms 25 Molecular Formula 25 Molecular Weight 25 Synthesis 25 D-2-Chlorophenylglycine 25 Synonyms 26 Molecular Formula 26 Molecular Weight 26 Structure 26 D-Penicillamine 26 Synonyms 26 Molecular Formula 26 Molecular Weight 26 Synthesis 26 IUPAC Name 26 DL-Amino Acids & Derivatives 27 DL-Alanine 27 Synonyms 27 Molecular Formula 27 Molecular Weight 27 Structure 27 Synthesis 27 Biosynthesis 27 Chemical Synthesis 28 IUPAC Name 28 DL-Methionine 28 Synonyms 28 Molecular Formula 28 Molecular Weight 28 Structure 28 IUPAC Name 29 DL-Phenylalanine 29 Synonyms 29 Molecular Formula 29 Molecular Weight 29 IUPAC Name 29 L-Amino Acid Derivatives 29 L-Homophenylalanine 29 Synonyms 30 Molecular Formula 30 Molecular Weight 30 Structure 30 Synthesis 30 IUPAC Name 30 L-Dopa 30 Synonyms 30 Molecular Formula 30 Molecular Weight 31 Structure 31 Synthesis 31 Electroenzymatic synthesis of L-Dopa 31 IUPAC Name 31 L-p-hydroxy phenylglycine 31 Other 31 Gamma-Amino Butyric Acid (GABA) 31 Synonyms 32 Molecular Formula 32 Molecular Weight 32 Structure 32 IUPAC Name 32 Gamma-Amino-Beta-Hydroxybutyric Acid (GABOB) 32 Molecular Formula 32 Molecular Weight 32 IUPAC Name 32 Synthetic α-Amino Acids 32 L-Thyroxine 32 Molecular Formula 32 Molecular Weight 33 Structure 33 IUPAC Name 33 3,5,3',5'-Tetraiodo-L-thyronine 33 Levothyroxine Recommendations 34 L-Thyroxine Associated side effects 34 L-Thyroxine for Veterinary application 34 Synthroid 34 FDA Guidelines 35 Boc-Protected Amino Acids 35 Fmoc-Protected Amino Acids 35 Synthetic Biology – An Overview 35 Unnatural Amino Acids and Biochemistry 36 Unnatural Amino Acids and Chirality 37 Unnatural Amino Acids – The Future of the Pharmaceutical Industry 38 2.3 Global Market Analysis 39 Exhibit 2. Unnatural Amino Acids - Global Historic Value Market (2005-2010) in US$ Million 40 Exhibit 3. Unnatural Amino Acids - Global Value Market Estimations & Predictions (2011-2020) in US$ Million 41 Exhibit 4. Unnatural Amino Acids - Global Historic Volume Market (2005-2010) in Million Metric Tons 42 Exhibit 5. Unnatural Amino Acids - Global Volume Market Estimations & Predictions (2011-2020) in Million Metric Tons 43 Exhibit 6. List of Global Major Unnatural Amino Acids Companies 43 3. MARKET DYNAMICS 46 3.1 Unnatural Amino Acids – A Market Overview 46 Anti-Infectives – Antiviral and Antibacterial Drugs 46 Cephalosporins Market 47 Regulatory Guidelines for Drugs 50 Sweeteners 51 Agrochemicals 51 3.2 Global Unnatural Amino Acids Market 53 Exhibit 7. Unnatural Amino Acids - Global Historic Value Market (2005-2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 53 Exhibit 8. Unnatural Amino Acids - Global Value Market Estimations & Predictions (2011-2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 54 Exhibit 9. Unnatural Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 55 3.3 North American Unnatural Amino Acids Market 56 North American Unnatural Amino Acids market was reported at US$ 8.11 billion in 2005, that increased at a CAGR of 16.22% to reach US$ 17.19 billion in 2010, during the period (2005-2010). 56 Exhibit 10. Unnatural Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million 56 Exhibit 11. Unnatural Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million 57 Exhibit 12. Unnatural Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada 58 3.3 (I) United States Unnatural Amino Acids Market 58 3.3 (II) Canadian Unnatural Amino Acids Market 58 Exhibit 13. List of Major North American Unnatural Amino Acids Companies 58 3.4 European Unnatural Amino Acids Market 59 Exhibit 14. Unnatural Amino Acids – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 59 Exhibit 15. Unnatural Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 60 Exhibit 16. Unnatural Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe 61 3.4 (I) United Kingdom Unnatural Amino Acids Market 61 3.4 (II) German Unnatural Amino Acids Market 61 3.4 (III) Swiss Unnatural Amino Acids Market 61 3.4 (IV) Italian Unnatural Amino Acids Market 61 3.4 (V) Dutch Unnatural Amino Acids Market 61 3.4 (VI) Russian Unnatural Amino Acids Market 62 Exhibit 17. List of Major European Unnatural Amino Acids Companies 62 3.5 Asia-Pacific Unnatural Amino Acids Market 63 Asia-Pacific Unnatural Amino Acids market was reported at US$ 4.7 billion in 2005 that increased at a CAGR of 17.40% to reach around US$ 10.6 billion in 2010, during the analysis period (2005-2010). 63 Exhibit 18. Unnatural Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 63 Exhibit 19. Unnatural Amino Acids – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 64 Exhibit 20. Unnatural Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific 65 3.5 (I) Chinese Unnatural Amino Acids Market 65 3.5 (II) Japanese Unnatural Amino Acids Market 65 3.5 (III) Indian Unnatural Amino Acids Market 65 Exhibit 21. List of Unnatural Amino Acids and their Import Prices to India 66 Exhibit 22. List of Unnatural Amino Acid and their Local Prices 66 3.5 (IV) South Korean Unnatural Amino Acids Market 67 3.5 (VI) Australian Unnatural Amino Acids Market 68 Exhibit 23. List of Major Asia-Pacific Unnatural Amino Acids Companies 68 3.6 Rest of World Unnatural Amino Acids Market 69 Exhibit 24. Unnatural Amino Acids - Rest of World Historic Value Market (2005-2010) for Brazil, South Africa, Israel and Other Countries in US$ Million 69 Exhibit 25. Unnatural Amino Acids - Rest of World Value Market Estimations & Predictions (2011-2020) Brazil, South Africa, Israel and Other Countries in US$ Million 70 Exhibit 26. Unnatural Amino Acids - Rest of World Value Market Shares (2008, 2012 & 2020) for Brazil, South Africa, Israel and Other Countries 71 3.6 (I) Brazilian Unnatural Amino Acids Market 71 3.6 (II) South African Unnatural Amino Acids Market 71 3.6 (III) Israeli Unnatural Amino Acids Market 71 3.7 Unnatural Amino Acids – Major Competitor Profiles 72 AbbVie, Inc. (USA) 72 ACS Dobfar SpA (Italy) 73 Æterna Zentaris, Inc. (Canada) 75 Ajinomoto Co., Inc. (Japan) 75 Amatek Chemical Co., Ltd. (Hong Kong) 76 AminoLogics Co. Ltd. (South Korea) 77 AnaSpec, Inc. (USA) 78 Aspen Pharmacare Holdings Ltd. (South Africa) 79 AstraZeneca plc (UK) 79 Bajaj Healthcare Ltd. (India) 81 BASF SE (Germany) 81 Bayer CropScience AG (Germany) 82 Biological E Ltd. (India) 83 Biovet SA (Spain) 84 Central Life Sciences (USA) 85 Corden Pharma International GmbH (Germany) 87 CSPC Pharmaceutical Group Limited (Hong Kong) 88 C-TRI Co., Ltd. (South Korea) 90 Divis Laboratories Ltd. (India) 91 Donboo Amino Acid Co., Ltd. (China) 92 DSM Sinochem Pharmaceuticals (Singapore) 93 EMD Millipore (USA) 94 EMD Serono, Inc. (USA) 105 Enzo Life Sciences, Inc. (USA) 105 Evonik Industries AG (Germany) 106 GlaxoSmithKline plc (UK) 108 Hanmi Pharmaceutical Co., Ltd. (South Korea) 110 Harbin Pharmaceutical Group Co., Ltd. (China) 112 Hovid Berhad (Malaysia) 112 IRIS Biotech GmbH (Germany) 114 Kyowa Hakko Bio Co., Ltd. (Japan) 150 Lek d.d. (Slovenia) 151 Lunan Pharmaceutical Group Corporation (China) 152 Lupin Pharmaceuticals, Inc. (USA) 153 Mimotopes Pty. Ltd. (Australia) 154 MP Biomedicals, LLC (USA) 154 Nagase & Co., Ltd. (Japan) 164 Norbrook Laboratories Ltd. (UK) 165 Novartis AG (Switzerland) 167 Orchid Chemicals & Pharmaceuticals Ltd. (India) 167 Pfizer, Inc. (USA) 171 PolyPeptide Group (The) (Denmark) 172 Ranbaxy Laboratories Ltd. (India) 172 Sandoz International GmbH (Germany) 173 Sanofi SA (France) 175 Sekisui Medical Co., Ltd. (Japan) 176 Shanghai Hanhong Chemical Co., Ltd. (China) 179 Shanghai HC Biotech Co., Ltd. (China) 179 Shanghai PanQi Biochem Tech Co., Ltd. (China) 181 Sigma-Aldrich Co. LLC (USA) 182 Synthetech, Inc. (USA) 184 Tocris Bioscience (USA) 185 Topsun International Group Co., Ltd. (China) 185 Unibiochem Co., Ltd. (China) 186 United Laboratories International Holdings Limited (The) (Hong Kong) 188 Venus Remedies Ltd. (India) 190 Xeno Pharmaceuticals Phils, Inc. (Philippines) 192 Zhangjiagang Huachang Pharmaceutical Co., Ltd. (China) 192 3.8 Major Activities in Unnatural Amino Acids Market 193 Yungjin Pharmaceuticals Cooperative Limited Expands Business in China 193 Venus Remedies Limited to Venture Italy 193 Ceftobiprole, the Antibiotic of Basilea, Granted Regulatory Approval for Pneumonia in Europe 193 Cephalosporin Oral Solid Certified With EU-GMP 194 DSM Sinochem Pharmaceuticals Launches Puriclor® (cefaclor), the Latest Member of its Unique Enzymat 194 Abbott Diversifies Research-Based Pharmaceuticals Business 194 Pernix Therapeutics Acquires Somaxon Pharmaceuticals 195 BPI Introduces New and Advanced Pre-Workout PUMP-HD™ 195 Orchid Chemicals and Pharmaceuticals to withdraw from its Chinese Joint Venture 195 Actavis Completely Acquired by Watson 195 Pfizer Completes Sale of Nutrition Business to Nestlé 196 Sagent Pharmaceuticals Launches Nafcillin for Injection, USP 196 Ajinomoto Co. Enters into a JV with Genexine Co. Ltd., for Production and Marketing of Serum Free Medium for Biopharmaceuticals 196 Actavis - Watson New Name for Global Operations 196 Ajinomoto Co. Establishes a JV in Indonesia to Produce Cosmetic Components 197 Kyowa Hakko Bio to Set Up a New Amino Acid Producing Unit as well as Subsidiary plant in Thailand 197 Pfizer and Hisun Launch Hisun-Pfizer Pharmaceuticals Co., Ltd 198 Bayer Crop Science Acquires Agraquest 198 European Commission Approves ZINFORO™ (ceftaroline fosamil) for Adult Patients with Serious Skin Infections or Community Acquired Pneumonia 198 Orchid Pharma Enters into a Business Transfer Agreement (BTA) with Hospira to transfer its Penicillin and Penem API business and its API Unit in Aurangabad 198 Sagent Pharmaceuticals Launches Oxacillin for Injection, USP 199 Derma Sciences Acquires Global Long-Term Exclusive Rights to NIMBUS Technology from Quick-Med Technologies 199 Stauber Performance Ingredients Acquires Florida based Pharmline 199 Zinforo (ceftaroline fosamil) Receives Positive CHMP Opinion in the European Union for the Treatment of Patients with Serious Skin Infections or Community Acquired Pneumonia 200 Sigma Aldrich Takes Over Research Organics Materials 200 Pernix Therapeutics Acquires Cypress Pharmaceuticals and Hawthorn Pharmaceuticals 200 Manufacture of Non-Natural Amino acids and ARCA 200 Evonik Plans to Setup Methionine Production Plant in Singapore 200 Cubist Pharmaceuticals Acquires Adolor Corporation 201 Actavis Takes Over Dutch Company PharmaPack International 201 Natural Alternatives International Receives New US Beta-Alanine Patent Protecting CarnoSyn® Products 201 Hospira Launches Imipenem- cilastatin for Injection and IV 201 Baxter Acquires Baxa Corporation 202 Enamine Launches Peptide Synthesis Laboratory 202 Astra Zeneca and Forest Labs Initiates Phase III Clinical Trials for Ceftazidime /Avibactam for Treatment of Gram-Negative Bacterial Infections 202 Bristol-Myers Squibb Enters into Collaboration with Ambrx Announce for Novel Biologics Programs in Diabetes and Heart Failure 202 Aurobindo Pharma and Russia based Diod Establishes Joint Venture to Manufacture and Market Generic Drugs in Russia 203 Alkermes Inc., Merges with Elan Drug Technologies 203 Kyowa Hakko Kirin Submits Additional Indication Application for Synthesized Penicillin "PASETOCIN®" 203 AMINO GmbH and Danisco A/S Enters into Cooperation Agreement Encompassing Fermentation of Amino Acids 204 Kyowa Hakko Bio Announces Commercial Production of cis-4-Hydroxy-L-proline 204 Sanofi-Aventis Completes Acquisition of Genzyme Corporation 204 Alcon and Novartis Complete Merger to create New Alcon Division with Global Leadership in Eye Care 205 Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group 205 Dr. Reddy’s Acquires GSK’s US Penicillin Facility 206 Reanal in Association with Celtic Catalysts Provides Difficult-to-Make Amino Acids for Peptide Market 206 Genzyme Completes Sale of Diagnostic Products Business to Sekisui Chemical Co. 206 Sutro Biopharma Enters into Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide- Based Therapeutics 206 Nutrena® Brand of Cargill Launches NatureWise® Range of Natural Poultry Feeds and Country Feeds® for Poultry 207 Bristol-Myers Squibb and Sanofi-Aventis Receive Approval for Pediatric Exclusivity for PLAVIX(R) (Clopidogrel Bisulfate) from the US FDA 208 Aspen Acquires Sigma's Pharmaceutical Business 208 Albion Obtains Patent for Hypoallergenic Metal Chelates 208 Grace Buys Stake in Synthetech 209 Venus Remedies Attains GMP Certification from Saudi Arabia (SFDA) 209 Pfizer through King Pharma Acquisition Widens the Company’s Presence in the Pain Drugs Market 210 USDA-ARS Enters into Partnership with Ajinomoto 210 Nestlé Performance Nutrition unveils the New PowerBar® Elite Series HIGH INTENSITY dietary supplement 210 VENUS attains EU patent for the investigated drug - SULBACTOMAX 211 Abbott Launches EAS Peak™ with P3 Technology 211 Abbott Introduces New Nutritional Shakes 212 Venus Pharma Receives Market Approval for the Proprietary Carbapenem Injection in Portugal 213 Merck KGaA Acquires Millipore and Forms New EMD Millipore Division 213 FDA Approves Hospira’s Generic Version of Antibiotic Merrem 213 Arbuckle’s Planet Rice Record Swelling Sales 214 The US Patent and Trademark Office Issues Notice of Allowance for MultiStat® Group of Compounds of Quick-Med Technologies 214 Orchid Acquires Karalex Pharma, LLC 215 Low-cost Drug to Save Thousands of Accident Victims 215 Ethical Naturals Develops AlphaWave™, a GRAS Approved L-Theanine 215 US FDA Approves Aurobindo Pharma’s Ceftazidime for Injection 216 Strides Arcolab Obtains FDA Approval for Bacitracin Injections 216 First Generic Version of Augmentin XR Launched in the US by Sandoz 216 Victory Pharma Acquires Assets of MiddleBrook Pharmaceutical for US$ 17.1 Million 217 FDA Approves DUPLEX® System of B.Braun for Administration of Cefepime 217 Ceftobiprole Sales to be Discontinued in Canada 217 Health Canada Approves Cefprozil Tablets & Powder for Oral Suspension of Aurobindo 218 MDRNA, Inc. and Pfizer in Joint Research Study 218 Novel Peptide Synthesis and Manufacturing Services Launched by Ajinomoto AminoSciences 218 AstraZeneca Acquires Novexel 219 FDA Approves Florida Based Cephalosporin Manufacturing Facility of GeoPharma 220 Pernix Therapeutics Holdings Acquires CEDAX, an Oral Third-Generation Cephalosporin 220 Venus Remedies Obtains Patent for SULBACTOMAX 220 Studies Indicate Ineffectiveness of Starlix, the Diabetes Drug of Novartis 221 Hospira Acquires Injectables Formulation Business of Orchid 221 Mefoxin® (cefoxitin injection) Frozen Premix IV Solution Launched by Bioniche Pharma 221 Antibiotics Prices in India likely to Increase Up to 50% 222 Chinese SFDA Approves Penicillin Manufacturing Facility of Suzhou Erye Pharmaceutical 222 Queensland Institute of Medical Research Awards Major Peptide Supply Contract to Mimotopes for Malaria Vaccine Research 223 AminoLogics Uses Novel Chiral Technology (ARCA) for Unnatural Amino Acids 223 Æterna Zentaris Terminates Agreement to Develop, Commercialize and License Cetrorelix in Benign Prostatic Hyperplasia with Sanofi-Aventis 223 Cubist Pharmaceuticals Formally Acquires Calixa Therapeutics 224 La Jolla Institute Awards Peptide Library Supply Contract to Screen Dengue & Tuberculosis Pathogens to Mimotopes 224 Drug Precursor for Cardiovascular Diseases Treatment Developed at USM 224 Venus Remedies Obtains South African Patent for Potentox 225 AnaSpec Acquired by Eurogentec 225 Online Peptide Superstore Launched by Mimotopes 226 American Peptide Company Creates Research & Development Division 226 AnaSpec Appoints Distributor in South Africa 227 Generic Nateglinide for Diabetes Launched in the US by Dr Reddy’s 227 Steri-Pharma Acquires Cephalosporin Manufacturing Facility from Hanford Pharmaceuticals 227 Swissmedic Approves Aurobindo Pharma’s Cefepime for Injection 227 AstraZeneca and Forest in Ceftaroline Co-development and Commercialization Agreement 228 FDA Declares Cefepime Appropriate 228 Penicillin G Potassium for Injection, USP, of APP Pharmaceuticals Approved by FDA 228 Generic Version of Vantin® Launched in the US by Sandoz 229 Venus Remedies Obtains First Product Patent in South Korea 229 Evonik Plans Substantial Methionine Manufacturing Capacity Expansion 229 AnaSpec Appoints Distributor for Lithuania & Latvia 230 Piperacillin/Tazobactam for Injection Launched in the UK by Hospira 230 ClearPoint™ Peptides of AnaSpec Bestowed Best New Product Award 230 Pfizer and Aurobindo Pharma Expand agreement from 5 Drugs to 44 drugs 230 AnaSpec Offers to Provide Custom Synthesis of Stapled Helical Peptides 231 FIRMAGON® (degarelix) of Ferring Pharmaceuticals Approved by European Commission as Prostate Cancer Treatment 231 Lundbeck Takes Over Ovation Pharmaceuticals 231 Sagent Pharmaceuticals Launches Cefazolin for Injection, USP in 500mg Single-dose Vial to Expand Cefazolin Product Range 232 AnaSpec Appoints BioPike as Distributor for China 232 CPC Scientific and Sigma-Aldrich in PEPscreen® Custom Peptide Libraries Distribution Agreement 232 FDA/NCIMS Approves BetaStar® Dairy Antibiotic Test of Neogen 233 AnaSpec Appoints Yope Biotechnology as Distributor 233 FDA Approves Generic Version of Augmentin Suspension 233 Zevtera Approved in Switzerland as Complicated Skin & Soft Tissue Infection Treatment 233 Evonik Enhances Methionine Production Capacity 234 AnaSpec and Shanghai Universal Biotech in Distribution Agreement 234 FDA Grants US Marketing Approval to Ceftazidime Injection of Wockhardt 234 Wockhardt Obtains Marketing Approval for Ceftazidime Injections from FDA 235 Zosyn®, an Injectable Semi-synthetic Antibiotic & ß-lactamase Inhibitor Combination Launched in Japan 235 Taisho Launches of Zosyn® in Japan 235 Merck and Orchid in Anti-infection Drugs Development Collaboration 236 AnaSpec and Biocore in Distribution Agreement 236 Venus Remedies Launches its Fourth Research Product 236 Injectables Ceftriaxone and Cefuroxime Launched by Sagent Pharmaceuticals 237 Cubist to Promote Merrem IV of AstraZeneca in the US 237 Novartis Acquires Protez Pharmaceuticals Along With Rights to Hospital Antibiotic in Clinical Development 237 Lupin Launches Ramipril Capsules 237 Inquiries Follow Nagase in Concurrence with Reinforcement of Unnatural Amino Acids 238 Protez Initiates Phase II Clinical Trials for PZ-601 in Infectious Diseases 238 Achillion and FOB Synthesis to Develop Carbapenem Compounds in Collaboration 238 Novartis Acquires Stake in Alcon 239 Strategic Acquisition by Aurobindo Pharma for Expansion in Europe 239 AOAC Approves BetaStar® Dairy Antibiotic Test of Neogen 239 FDA Grants Manufacturing & Marketing Approval of Cefuroxime Axetil to Ranbaxy 240 Cefuroxime Axetil for Oral Suspension of Ranbaxy Approved in the US 240 Amoxicillin of MiddleBrook Approved by FDA for Pharyngitis/Tonsillitis in Adults and Adolescents 240 DSM Anti-Infectives and Arch Pharmalabs in Partnership Agreement 241 US FDA Approves Cefpodoxime Proxetil ANDA of Orchid 241 NeoMPS Acquired by PolyPeptide Group 241 Eli Lilly Sells Indian Marketing Rights of Antibiotic Distaclor® (Cefaclor) to Pharmalink 242 FDA Approves Aurobindo Pharma’s Cefazolin for Injection USP 242 Advancis Pharmaceutical Corporation Renamed MiddleBrook Pharmaceuticals, Inc 242 Lupin Obtains FDA Approval for Cefdinir for Oral Suspension, 250mg/ 5ml, to Launch Entire Product Range 242 Bachem in Expanded Peptide Production Co-operation with Immatics 242 Æterna Zentaris Reclaims Exclusive Global Rights (Ex-Japan) from Solvay for Cetrorelix 243 Charm Sciences Launches ROSA® SL3™ 243 FDA Approves Suprax of Lupin Pharmaceuticals 243 FDA Grants US Marketing Approval for Complete Range of Ceftriaxone Antibiotic Injection to Wockhardt 244 FDA Grants Marketing Approval to Wockhardt for Complete Range of Ceftriaxone Antibiotic Injections 244 Cephalosporin Injectable Manufacturing Facility Approved 244 Orchid in Licensing and Distribution Agreement with Actavis for Marketing of Cephalosporin Formulations in Entire Europe 244 FDA Grants Marketing Approval for Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, to Ranbaxy 245 FDA Marketing Approval to Ranbaxy for Amoxicillin and Clavulanate Potassium for Oral Suspension USP 245 FDA Grants Manufacturing and Marketing Approval of Cefprozil Anti-infective Tablets to Ranbaxy Laboratories 246 Æterna Zentaris Launches Cetrotide® (Cetrorelix) in Japan for In-Vitro Fertilization 246 FDA Approves Ceftriaxone 10gm Vials of Lupin 246 FDA Marketing Approval to Wockhardt for Cefotaxime Injection 246 Advancis Launches Keflex 750mg Capsules 247 Carbapenem Antibiotic Finibax 0.25g IV Solution Kit (Doripenem Hydrate) Launched in Japan by Shionogi 247 Brookwood and Genzyme in an Expansive Drug Delivery Collaboration 247 FDA Approves Cephalexin Capsules of Aurobindo Pharma 247 Polymer Launches New Resin for Solid-phase Synthesis of Resin-Bound Unnatural Amino Acids 248 US FDA Approves Ceftriaxone Vials of Orchid 248 FDA Approves Baxter’s Frozen Premixed Ceftriaxone Injection in Ready-to-Use Containers 248 Advancis Launches Keflex® Powder for Oral Suspension in the US 248 Ranbaxy Introduces Chewable Cephalosporin Tablet 249 3.9 Unnatural Amino Acids – Market Analysis by Type 250 Type Analysis 250 Exhibit 27. Unnatural Amino Acids – Global Historic Value Market (2005 - 2010) by Type for D-Amino Acid Derivatives, L-Amino Acid Derivatives, Cyclic Amino Acid & Derivatives, β-Amino Acid Derivatives, D-Amino Acids, β-Amino Acids, DL-Amino Acids, DL-Amino Acid Derivatives and Other in US$ Million 251 Exhibit 28. Unnatural Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Type for D-Amino Acid Derivatives, L-Amino Acid Derivatives, Cyclic Amino Acid & Derivatives, β-Amino Acid Derivatives, D-Amino Acids, β-Amino Acids, DL-Amino Acids, DL-Amino Acid Derivatives and Other in US$ Million 252 Exhibit 29. Unnatural Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Type for D-Amino Acid Derivatives, L-Amino Acid Derivatives, Cyclic Amino Acid & Derivatives, β-Amino Acid Derivatives, D-Amino Acids, β-Amino Acids, DL-Amino Acids, DL-Amino Acid Derivatives and Other 253 Type Analysis by Region 255 3.9.1 D-Amino Acid Derivatives 255 3.9.1.1 Global D-Amino Acid Derivatives Market 256 Exhibit 30. D-Amino Acid Derivatives - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 256 Exhibit 31. D-Amino Acid Derivatives - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 257 Exhibit 32. D-Amino Acid Derivatives - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 258 D-Amino Acids and Derivatives 259 Exhibit 33. D-Amino Acids and Derivatives - Global Production Market Estimations and Predictions (2005-2020) in Metric Tons 259 D-Phenylglycine and p-hydroxy-D-phenylglycine 260 Exhibit 34. D-Phenylglycine and p-hydroxy-D-phenylglycine - Global Production Market Estimations and Predictions (2005-2020) in Metric Tons 260 p-hydroxy-D-phenylglycine 261 Exhibit 35. p-hydroxy-D-phenylglycine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 261 D-phenylglycine 262 Exhibit 36. D-phenylglycine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 262 D-2-Chlorophenylglycine 263 Exhibit 37. D-2-Chlorophenylglycine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 263 D-Penicillamine 264 Exhibit 38. D-Penicillamine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 264 D-2-Naphthylalanine 265 Exhibit 39. D-2-Naphthylalanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 265 Exhibit 40. List of Global D - Amino Acids Derivatives Companies 266 3.9.1.2 North American D-Amino Acid Derivatives Market 267 Exhibit 41. D-Amino Acid Derivatives - North American Historic Value Market (2005 - 2010) by Country for United States and Canada in US$ Million 267 Exhibit 42. D-Amino Acid Derivatives - North American Value Market Estimations & Predictions (2011 - 2020) by Country for United States and Canada in US$ Million 268 Exhibit 43. D-Amino Acid Derivatives - North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada 269 3.9.1.2 (I) United States D-Amino Acid Derivatives Market 269 3.9.1.2 (II) Canadian D-Amino Acid Derivatives Market 269 3.9.1.3 European D-Amino Acid Derivatives Market 270 Exhibit 44. D-Amino Acid Derivatives - European Historic Value Market (2005 - 2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 270 Exhibit 45. D-Amino Acid Derivatives - European Value Market Estimations & Predictions (2011 - 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 271 Exhibit 46. D-Amino Acid Derivatives - European Value Market Shares (2008, 2012 & 2012) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe 272 3.9.1.3 (I) United Kingdom D-Amino Acid Derivatives Market 272 3.9.1.3 (II) German D-Amino Acid Derivatives Market 272 3.9.1.3 (III) Swiss D-Amino Acid Derivatives Market 272 3.9.1.3 (IV) Italian D-Amino Acid Derivatives Market 272 3.9.1.3 (V) Dutch D-Amino Acid Derivatives Market 273 3.9.1.3 (VI) Russian D-Amino Acid Derivatives Market 273 3.9.1.4 Asia-Pacific D-Amino Acid Derivatives Market 274 Exhibit 47. D-Amino Acid Derivatives - Asia-Pacific Historic Value Market (2005 - 2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 274 Exhibit 48. D-Amino Acid Derivatives - Asia-Pacific Value Market Estimations & Predictions (2011 - 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 275 Exhibit 49. D-Amino Acid Derivatives - Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific 276 3.9.1.4 (I) Chinese D-Amino Acid Derivatives Market 276 3.9.1.4 (II) Japanese D-Amino Acid Derivatives Market 276 3.9.1.4 (III) Indian D-Amino Acid Derivatives Market 276 3.9.1.4 (IV) South Korean D-Amino Acid Derivatives Market 276 3.9.1.4 (V) Australian D-Amino Acid Derivatives Market 276 3.9.1.5 Rest of World D-Amino Acid Derivatives Market 277 Exhibit 50. D-Amino Acid Derivatives – Rest of World Historic Value Market (2005 - 2010) by Country Brazil, South Africa, Israel and Other Countries in US$ Million 277 Exhibit 51. D-Amino Acid Derivatives – Rest of World Value Market Estimations & Predictions (2011 - 2020) by Country Brazil, South Africa, Israel and Other Countries in US$ Million 278 Exhibit 52. D-Amino Acid Derivatives – Rest of World Value Market Shares (2008, 2012 & 2020) by Country Brazil, South Africa, Israel and Other Countries 279 3.9.1.5 (I) Brazilian D-Amino Acid Derivatives Market 279 3.9.1.5 (II) South African D-Amino Acid Derivatives Market 279 3.9.1.5 (III) Israeli D-Amino Acid Derivatives Market 279 3.9.2 L-Amino Acid Derivatives 280 3.9.2.1 Global L-Amino Acid Derivatives Market 280 Exhibit 53. L-Amino Acid Derivatives - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 280 Exhibit 54. L-Amino Acid Derivatives - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 281 Exhibit 55. L-Amino Acid Derivatives - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 282 L-DOPA 283 Exhibit 56. L-Dopa - Global Value Market Estimations and Predictions (2005-2020) in US$ Billion 283 L-p-hydroxy-phenylglycine 284 Exhibit 57. L-p-hydroxy-phenylglycine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 284 L-Homophenylalanine 285 Exhibit 58. L-Homophenylalanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 285 L-homoalanine 286 Exhibit 59. L-homoalanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 286 Acetyl-L-Carnitine 287 Exhibit 60. Acetyl-L-Carnitine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 287 Exhibit 61. List of Global L - Amino Acids Derivatives Companies 288 3.9.2.2 North American L-Amino Acid Derivatives Market 289 Exhibit 62. L-Amino Acid Derivatives - North American Historic Value Market (2005 - 2010) by Country for United States and Canada in US$ Million 289 Exhibit 63. L-Amino Acid Derivatives - North American Value Market Estimations & Predictions (2011 - 2020) by Country for United States and Canada in US$ Million 290 Exhibit 64. L-Amino Acid Derivatives - North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada 291 3.9.2.2 (I) United States L-Amino Acid Derivatives Market 291 3.9.2.2 (II) Canadian L-Amino Acid Derivatives Market 291 3.9.2.3 European L-Amino Acid Derivatives Market 292 Exhibit 65. L-Amino Acid Derivatives - European Historic Value Market (2005 - 2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 292 Exhibit 66. L-Amino Acid Derivatives - European Value Market Estimations & Predictions (2011 - 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 293 Exhibit 67. L-Amino Acid Derivatives - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe 294 3.9.2.3 (I) United Kingdom L-Amino Acid Derivatives Market 294 3.9.2.3 (II) German L-Amino Acid Derivatives Market 294 3.9.2.3 (III) Swiss L-Amino Acid Derivatives Market 294 3.9.2.3 (IV) Italian L-Amino Acid Derivatives Market 294 3.9.2.3 (V) Dutch L-Amino Acid Derivatives Market 295 3.9.2.3 (VI) Russian L-Amino Acid Derivatives Market 295 3.9.2.4 Asia-Pacific L-Amino Acid Derivatives Market 296 Exhibit 68. L-Amino Acid Derivatives - Asia-Pacific Historic Value Market (2005 - 2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 296 Exhibit 69. L-Amino Acid Derivatives - Asia-Pacific Value Market Estimations & Predictions (2011 - 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 297 Exhibit 70. L-Amino Acid Derivatives - Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific 298 3.9.2.4 (I) Chinese L-Amino Acid Derivatives Market 298 3.9.2.4 (II) Japanese L-Amino Acid Derivatives Market 298 3.9.2.4 (III) Indian L-Amino Acid Derivatives Market 298 3.9.2.4 (IV) South Korean L-Amino Acid Derivatives Market 298 3.9.2.4 (V) Australian L-Amino Acid Derivatives Market 298 3.9.2.5 Rest of World L-Amino Acid Derivatives Market 299 Exhibit 71. L-Amino Acid Derivatives – Rest of World Historic Value Market (2005 - 2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 299 Exhibit 72. L-Amino Acid Derivatives – Rest of World Value Market Estimations & Predictions (2011 - 2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 300 Exhibit 73. L-Amino Acid Derivatives – Rest of World Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries 301 3.9.2.5(I) Brazilian L-Amino Acid Derivatives Market 301 3.9.2.5 (II) South African L-Amino Acid Derivatives Market 301 3.9.2.5 (III) Israeli L-Amino Acid Derivatives Market 301 3.9.3 Cyclic Amino Acids 302 3.9.3.1 Global Cyclic Amino Acids Market 302 Exhibit 74. Cyclic Amino Acids - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 302 Exhibit 75. Cyclic Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 303 Exhibit 76. Cyclic Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 304 D-CycloSerine 305 Exhibit 77. D-Cycloserine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 305 3.9.3.2 North American Cyclic Amino Acids Market 306 Exhibit 78. Cyclic Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million 306 Exhibit 79. Cyclic Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million 307 Exhibit 80. Cyclic Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada 308 3.9.3.2 (I) United States Cyclic Amino Acid Derivatives Market 308 3.9.3.2 (II) Canadian Cyclic Amino Acid Derivatives Market 308 3.9.3.3 European Cyclic Amino Acids Market 309 Exhibit 81. Cyclic Amino Acids – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 309 Exhibit 82. Cyclic Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 310 Exhibit 83. Cyclic Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe 311 3.9.3.3 (I) United Kingdom Cyclic Amino Acid Derivatives Market 311 3.9.3.3 (II) German Cyclic Amino Acid Derivatives Market 311 3.9.3.3 (III) Swiss Cyclic Amino Acid Derivatives Market 311 3.9.3.3 (IV) Italian Cyclic Amino Acid Derivatives Market 311 3.9.3.3 (V) Dutch Cyclic Amino Acid Derivatives Market 311 3.9.3.3 (VI) Russian Cyclic Amino Acid Derivatives Market 311 3.9.3.4 Asia-Pacific Cyclic Amino Acids Market 312 Exhibit 84. Cyclic Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 312 Exhibit 85. Cyclic Amino Acids – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 313 Exhibit 86. Cyclic Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific 314 3.9.3.4 (I) Chinese Cyclic Amino Acid Derivatives Market 314 3.9.3.4 (II) Japanese Cyclic Amino Acid Derivatives Market 314 3.9.3.4 (III) Indian Cyclic Amino Acid Derivatives Market 314 3.9.3.4 (IV) South Korean Cyclic Amino Acid Derivatives Market 314 3.9.3.4 (V) Australian Cyclic Amino Acid Derivatives Market 314 3.9.3.5 Rest of World Cyclic Amino Acids Market 315 Exhibit 87. Cyclic Amino Acids - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 315 Exhibit 88. Cyclic Amino Acids - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 316 Exhibit 89. Cyclic Amino Acids – Rest of World Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries 317 3.9.3.5 (I) Brazilian Cyclic Amino Acid Derivatives Market 317 3.9.3.5 (II) South African Cyclic Amino Acid Derivatives Market 317 3.9.3.5 (III) Israeli Cyclic Amino Acid Derivatives Market 317 3.9.4 β-Amino Acid Derivatives 318 3.9.4.1 Global β-Amino Acid Derivatives Market 318 Exhibit 90. β-Amino Acid Derivatives - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 318 Exhibit 91. β-Amino Acid Derivatives - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 319 Exhibit 92. β-Amino Acid Derivatives - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 320 β-Amino Alcohols 321 Exhibit 93. β-Amino Alcohols - Global Value Market Estimations & Predictions (2005-2020) in US$ Million 321 Exhibit 94. List of Global β-Amino Acids Derivatives Companies 322 3.9.4.2 North American β-Amino Acid Derivatives Market 323 Exhibit 95. β-Amino Acid Derivatives – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million 323 Exhibit 96. β-Amino Acid Derivatives – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million 324 Exhibit 97. β-Amino Acid Derivatives – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada 325 3.9.4.2 (I) United States β-Amino Acid Derivatives Market 325 3.9.4.2 (II) Canadian β-Amino Acid Derivatives Market 325 3.9.4.3 European β-Amino Acid Derivatives Market 326 Exhibit 98. β-Amino Acid Derivatives β-Amino Acid Derivatives – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 326 Exhibit 99. β-Amino Acid Derivatives – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 327 Exhibit 100. β-Amino Acid Derivatives - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe 328 3.9.4.3 (I) United Kingdom β-Amino Acid Derivatives Market 328 3.9.4.3 (II) German β-Amino Acid Derivatives Market 328 3.9.4.3 (III) Swiss β-Amino Acid Derivatives Market 328 3.9.4.3 (IV) Italian β-Amino Acid Derivatives Market 328 3.9.4.3 (V) Dutch β-Amino Acid Derivatives Market 329 3.9.4.3 (VI) Russian β-Amino Acid Derivatives Market 329 3.9.4.4 Asia-Pacific β-Amino Acid Derivatives Market 330 Exhibit 101. β-Amino Acid Derivatives – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 330 Exhibit 102. β-Amino Acid Derivatives – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 331 Exhibit 103. β-Amino Acid Derivatives – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific 332 3.9.4.4 (I) Chinese β-Amino Acid Derivatives Market 332 3.9.4.4 (II) Japanese β-Amino Acid Derivatives Market 332 3.9.4.4 (III) Indian β-Amino Acid Derivatives Market 332 3.9.4.4 (IV) South Korean β-Amino Acid Derivatives Market 332 3.9.4.4 (V) Australian β-Amino Acid Derivatives Market 332 3.9.4.5 Rest of World β-Amino Acid Derivatives Market 333 Exhibit 104. β-Amino Acid Derivatives - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 333 Exhibit 105. β -Amino Acid Derivatives - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 334 Exhibit 106. β-Amino Acid Derivatives – Rest of World Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries 335 3.9.4.5 (I) Brazilian β-Amino Acid Derivatives Market 335 3.9.4.5 (II) South African β-Amino Acid Derivatives Market 335 3.9.4.5 (III) Israeli β-Amino Acid Derivatives Market 335 3.9.5 D-Amino Acids 336 3.9.5.1 Global D-Amino Acids Market 336 Exhibit 107. D-Amino Acids - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 336 Exhibit 108. D-Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 337 Exhibit 109. D-Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 338 D-Alanine 339 Exhibit 110. D-Alanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 339 D-Arginine 340 Exhibit 111. D-Arginine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 340 D-Aspartic Acid 341 Exhibit 112. D-Aspartic Acid - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 341 D-Cysteine 342 Exhibit 113. D-Cysteine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 342 D-Leucine 343 Exhibit 114. D-Leucine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 343 D-Lysine 344 Exhibit 115. D-Lysine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 344 D-Phenylalanine 345 Exhibit 116. D-Phenylalanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 345 D-Serine 347 Exhibit 117. D-Serine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 347 D-Threonine 348 Exhibit 118. D-Threonine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 348 D-Tryptophan 349 Exhibit 119. D-Tryptophan - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 349 D-Tyrosine 350 Exhibit 120. D-Tyrosine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 350 D-Valine 351 Exhibit 121. D-Valine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 351 D-Glutamic Acid 352 Exhibit 122. D-Glutamic Acid - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 352 D-Proline 353 Exhibit 123. D-Proline - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 353 D-Histidine 354 Exhibit 124. D-Histidine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 354 Exhibit 125. List of Global D-Amino Acids Companies 355 3.9.5.2 North American D-Amino Acids Market 356 Exhibit 126. D-Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million 356 Exhibit 127. D-Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million 357 Exhibit 128. D-Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada 358 3.9.5.2 (I) United States D-Amino Acids Market 358 3.9.5.2 (II) Canadian D-Amino Acids Market 358 3.9.5.3 European D-Amino Acids Market 359 Exhibit 129. D-Amino Acids D-Amino Acids – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 359 Exhibit 130. D-Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 360 Exhibit 131. D-Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe 361 3.9.5.3 (I) United Kingdom D-Amino Acids Market 361 3.9.5.3 (II) German D-Amino Acids Market 361 3.9.5.3 (III) Swiss D-Amino Acids Market 361 3.9.5.3 (IV) Italian D-Amino Acids Market 361 3.9.5.3 (V) Dutch D-Amino Acids Market 361 3.9.5.3 (VI) Russian D-Amino Acids Market 361 3.9.5.4 Asia-Pacific D-Amino Acids Market 362 Exhibit 132. D-Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 362 Exhibit 133. D-Amino Acids – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 363 Exhibit 134. D-Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific 364 3.9.5.4 (I) Chinese D-Amino Acids Market 364 3.9.5.4 (II) Japanese D-Amino Acids Market 364 3.9.5.4 (III) Indian D-Amino Acids Market 364 3.9.5.4 (IV) South Korean D-Amino Acids Market 364 3.9.5.4 (V) Australian D-Amino Acids Market 364 3.9.5.5 Rest of World D-Amino Acids Market 365 Exhibit 135. D-Amino Acids - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 365 Exhibit 136. D-Amino Acids - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 366 Exhibit 137. D-Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries 367 3.9.5.5 (I) Brazilian D-Amino Acids Market 367 3.9.5.5 (II) South African D-Amino Acids Market 367 3.9.5.5 (III) Israeli D-Amino Acids Market 367 3.9.6 β-Amino Acids 368 3.9.6.1 Global β-Amino Acids Market 368 Exhibit 138. β-Amino Acids - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 368 Exhibit 139. β-Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 369 Exhibit 140. β-Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 370 β-Alanine 371 Exhibit 141. β-Alanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 371 Exhibit 142. List of Global β-Amino Acids Companies 372 3.9.6.2 North American β-Amino Acids Market 373 Exhibit 143. β-Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million 373 Exhibit 144. β-Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million 374 Exhibit 145. β-Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada 375 3.9.6.2 (I) United States β-Amino Acids Derivatives Market 375 3.9.6.2 (II) Canadian β-Amino Acids Derivatives Market 375 3.9.6.3 European β-Amino Acids Market 376 Exhibit 146. β-Amino Acids– European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 376 Exhibit 147. β-Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 377 Exhibit 148. β-Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe 378 3.9.6.3 (I) United Kingdom β-Amino Acids Market 378 3.9.6.3 (II) German β-Amino Acids Market 378 3.9.6.3 (III) Swiss β-Amino Acids Market 378 3.9.6.3 (IV) Italian β-Amino Acids Market 378 3.9.6.3 (V) Dutch β-Amino Acids Market 378 3.9.6.3 (VI) Russian β-Amino Acids Market 378 3.9.6.4 Asia-Pacific β-Amino Acids Market 379 Exhibit 149. β-Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 379 Exhibit 150. β-Amino Acids – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 380 Exhibit 151. β-Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific 381 3.9.6.4 (I) Chinese β-Amino Acids Market 381 3.9.6.4 (II) Japanese β-Amino Acids Market 381 3.9.6.4 (III) Indian β-Amino Acids Market 381 3.9.6.4 (IV) South Korean β-Amino Acids Market 381 3.9.6.4 (V) Australian β-Amino Acids Market 381 3.9.6.5 Rest of World β-Amino Acids Market 382 Exhibit 152. β-Amino Acids - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 382 Exhibit 153. β-Amino Acids - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 383 Exhibit 154. β-Amino Acids - Rest of World Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 384 3.9.6.5 (I) Brazilian β-Amino Acids Market 384 3.9.6.5 (II) South African β-Amino Acids Market 384 3.9.6.5 (III) Israeli β-Amino Acids Market 384 3.9.7 DL-Amino Acids 385 3.9.7.1 Global DL-Amino Acids Market 385 Exhibit 155. DL-Amino Acids - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 385 Exhibit 156. DL-Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 386 Exhibit 157. DL-Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 387 DL-Methionine 388 Exhibit 158. DL-Methionine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 388 DL-Alanine 389 Exhibit 159. DL-Alanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 389 DL-Phenylalanine 390 Exhibit 160. DL-Phenylalanine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 390 Exhibit 161. List of Global DL - Amino Acids Companies 391 3.9.7.2 North American DL-Amino Acids Market 393 Exhibit 162. DL-Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million 393 Exhibit 163. DL-Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million 394 Exhibit 164. DL-Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada 395 3.9.7.2 (I) United States DL-Amino Acids Market 395 3.9.7.2 (II) Canadian DL-Amino Acids Market 395 3.9.7.3 European DL-Amino Acids Market 396 Exhibit 165. DL-Amino Acids DL-Amino Acids – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 396 Exhibit 166. DL-Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 397 Exhibit 167. DL-Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe 398 3.9.7.3 (I) United Kingdom DL-Amino Acids Market 398 3.9.7.3 (II) German DL-Amino Acids Market 398 3.9.7.3 (III) Swiss DL-Amino Acids Market 398 3.9.7.3 (IV) Italian DL-Amino Acids Market 398 3.9.7.3 (V) Dutch DL-Amino Acids Market 398 3.9.7.3 (VI) Russian DL-Amino Acids Market 398 3.9.7.4 Asia-Pacific DL-Amino Acids Market 399 Exhibit 168. DL-Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 399 Exhibit 169. DL-Amino Acids – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 400 Exhibit 170. DL-Amino Acids – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific 401 3.9.7.4 (I) Chinese DL-Amino Acids Market 401 3.9.7.4 (II) Japanese DL-Amino Acids Market 401 3.9.7.4 (III) Indian DL-Amino Acids Market 401 3.9.7.4 (IV) South Korean DL-Amino Acids Market 401 3.9.7.4 (V) Australian DL-Amino Acids Market 401 3.9.7.5 Rest of World DL-Amino Acids Market 402 Exhibit 171. DL-Amino Acids - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 402 Exhibit 172. DL-Amino Acids - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 403 Exhibit 173. DL-Amino Acids - Rest of World Value Market Shares (2008, 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries 404 3.9.7.5 (I) Brazilian DL-Amino Acids Market 404 3.9.7.5 (II) South African DL-Amino Acids Market 404 3.9.7.5 (III) Israel DL-Amino Acids Market 404 3.9.8 DL-Amino Acid Derivatives 405 3.9.8.1 Global DL-Amino Acid Derivatives Market 405 Exhibit 174. DL-Amino Acid Derivatives - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 405 Exhibit 175. DL-Amino Acid Derivatives - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 406 Exhibit 176. DL-Amino Acid Derivatives - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 407 Exhibit 177. List of Global DL - Amino Acids Derivatives Companies 407 3.9.8.2 North American DL-Amino Acid Derivatives Market 408 Exhibit 178. DL-Amino Acid Derivatives – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million 408 Exhibit 179. DL-Amino Acid Derivatives – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million 409 Exhibit 180. DL-Amino Acid Derivatives – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada 410 3.9.8.2 (II) United States DL-Amino Acid Derivatives Market 410 3.9.8.2 (II) Canadian DL-Amino Acid Derivatives Market 410 3.9.8.3 European DL-Amino Acid Derivatives Market 411 Exhibit 181. DL-Amino Acid Derivatives DL-Amino Acid Derivatives – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 411 Exhibit 182. DL-Amino Acid Derivatives – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 412 Exhibit 183. DL-Amino Acid Derivatives - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe 413 3.9.8.3 (I) United Kingdom DL-Amino Acid Derivatives Market 413 3.9.8.3 (II) German DL-Amino Acid Derivatives Market 413 3.9.8.3 (III) Swiss DL-Amino Acid Derivatives Market 413 3.9.8.3 (IV) Italian DL-Amino Acid Derivatives Market 413 3.9.8.3 (V) Dutch DL-Amino Acid Derivatives Market 413 3.9.8.3 (VI) Russian DL-Amino Acid Derivatives Market 413 3.9.8.4 Asia-Pacific DL-Amino Acid Derivatives Market 414 Exhibit 184. DL-Amino Acid Derivatives – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 414 Exhibit 185. DL-Amino Acid Derivatives – Asia-Pacific Value Market Estimations & Predictions (2011-2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 415 Exhibit 186. DL-Amino Acid Derivatives – Asia-Pacific Value Market Shares (2008, 2012 & 2020) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific 416 3.9.8.4 (I) Chinese DL-Amino Acid Derivatives Market 416 3.9.8.4 (II) Japanese DL-Amino Acid Derivatives Market 416 3.9.8.4 (III) Indian DL-Amino Acid Derivatives Market 416 3.9.8.4 (IV) South Korean DL-Amino Acid Derivatives Market 416 3.9.8.4 (V) Australian DL-Amino Acid Derivatives Market 416 3.9.8.5 Rest of World DL-Amino Acid Derivatives Market 417 Exhibit 187. DL-Amino Acid Derivatives - Rest of World Historic Value Market (2005-2010) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 417 Exhibit 188. DL-Amino Acid Derivatives - Rest of World Value Market Estimations & Predictions (2011-2020) by Country for Brazil, South Africa, Israel and Other Countries in US$ Million 418 Exhibit 189. DL-Amino Acid Derivatives - Rest of World Value Market Shares (2008. 2012 & 2020) by Country for Brazil, South Africa, Israel and Other Countries 419 3.9.8.5 (I) Brazilian DL-Amino Acid Derivatives Market 419 3.9.8.5 (II) South African DL-Amino Acid Derivatives Market 419 3.9.8.5 (III) Israeli DL-Amino Acid Derivatives Market 419 3.9.9 Other Unnatural Amino Acids 420 3.9.9.1 Global Other Unnatural Amino Acids Market 420 Exhibit 190. Other Unnatural Amino Acids - Global Historic Value Market (2005 - 2010) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 420 Exhibit 191. Other Unnatural Amino Acids - Global Value Market Estimations & Predictions (2011 - 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million 421 Exhibit 192. Other Unnatural Amino Acids - Global Value Market Shares (2008, 2012 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World 422 GABA (Gamma Amino Butyric Acid) 423 Exhibit 193. GABA - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 423 L-Thyroxine 424 Exhibit 194. L-Thyroxine - Global Value Market Estimations and Predictions (2005-2020) in US$ Million 424 3.9.9.2 North American Other Unnatural Amino Acids Market 425 Exhibit 195. Other Unnatural Amino Acids – North American Historic Value Market (2005-2010) by Country for United States and Canada in US$ Million 425 Exhibit 196. Other Unnatural Amino Acids – North American Value Market Estimations & Predictions (2011-2020) by Country for United States and Canada in US$ Million 426 Exhibit 197. Other Unnatural Amino Acids – North American Value Market Shares (2008, 2012 & 2020) by Country for United States and Canada 427 3.9.9.3 European Other Unnatural Amino Acids Market 428 Exhibit 198. Other Unnatural Amino Acids Other Unnatural Amino Acids – European Historic Value Market (2005-2010) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 428 Exhibit 199. Other Unnatural Amino Acids – European Value Market Estimations & Predictions (2011-2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe in US$ Million 429 Exhibit 200. Other Unnatural Amino Acids - European Value Market Shares (2008, 2012 & 2020) by Country for United Kingdom, Germany, Switzerland, Italy, the Netherland, Russia and Rest of Europe 430 Asia-Pacific Other Unnatural Amino Acids Market 431 Exhibit 201. Other Unnatural Amino Acids – Asia-Pacific Historic Value Market (2005-2010) by Country for China, Japan, India, South Korea, Australia and Rest of Asia-Pacific in US$ Million 431 Exhibit 202. Othe
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
